Breaux/Frist Medicare Board Is One Sore Spot In Rx Firms' Favored Bill

A federal Medicare Board will likely be one of the most sensitive issues for the brand name pharmaceutical industry in deciding how enthusiastically to support Medicare reform legislation introduced Nov. 9 by Sens. Breaux (D-La.), Frist (R-Tenn.), Kerrey (D-Neb.) and Hagel (R-Neb.).